Blog
RSS FeedPosted by Michael Wonder on 17 Nov 2016
NICE approves three quarters of CDF group 1 drugs for routine use
17 November 2016 - More than 75% of treatments in the Cancer Drugs Fund which have been looked at again by ...
Posted by Michael Wonder on 02 Aug 2016
Rare cancer drug which significantly delays progression of advanced thyroid cancer is left off relaunched Cancer Drugs Fund
2 August 2016 - People with radioiodine refractory differentiated thyroid cancer are overlooked as Lenvima (lenvatinib mesylate) is not scheduled for ...
Posted by Michael Wonder on 08 Jul 2016
Japan's Eisai weighs legal action in UK cancer drug row
8 July 2016 - Japan's Eisai said on Friday it would consider all options, including possible legal action, to fight delays ...
Posted by Michael Wonder on 07 Jul 2016
Pfizer drug wins U.K. support following overhaul of Cancer Fund
7 July 2016 - Drug costs $58,000 a year before discounts from Pfizer. ...
Posted by Michael Wonder on 04 Sep 2015
Celgene threatens to scale back UK clinical trial investment after CDF snub
4 September 2015 - One of the world’s leading pharma companies in oncology is considering whether to continue investing in clinical ...
Posted by Michael Wonder on 04 Sep 2015
Thousands of cancer patients to be denied treatment
4 September 2015 - More than 5,000 cancer patients will be denied life-extending drugs under plans which charities say are a ...
Posted by Michael Wonder on 04 Sep 2015
Cancer drugs fund cuts 23 treatments
4 September 2015 - The Cancer Drugs Fund in England will no longer pay for 16 medicines, used in 23 separate ...
Posted by Michael Wonder on 04 Sep 2015
Cancer Drugs Fund delisting of Kadcyla - September 2015
4 September 2015 - Roche has taken to YouTube to explain the imminent delisting of Kadcyla from the Cancer Drugs Fund. ...
Posted by Michael Wonder on 04 Sep 2015
Life-extending cancer drugs to be axed by NHS
4 September 2015 - New and costly cancer drugs developed to extend the lives of patients are expected to be axed ...